Profile
PD Dr. Wildhaber joined BioMedPartners in January 2007.
Previously, she was a Managing Director for the Novartis Venture Fund where she served on the boards of Athelas, NanoPowers, CellnTec and Oncalis.
She has more than 19 years of experience in pharmaceutical R&D and business development.
In Novartis, she was Head of Immunology Project Management, Immunology Research, Oncology Business Development and Licensing as well as a member of the Corporate Mergers and Acquisition team.
Prior to joining Novartis, Dr. Wildhaber performed postdoctoral research on tumor virology (FMI-Basel), membrane proteins and lipids (ETH-Zurich) and monoclonal antibodies and crystallisation of bacterial photosynthetic proteins (MPI-Munich).
Her qualifications include a Biochemistry B.Sc.
(UK), Ph.D (performed at Max Planck Institute for Immunology, Freiburg) and PD (Privatdozentin) from the ETH-Zurich.
Former positions of Frances Wildhaber
| Companies | Position | End |
|---|---|---|
BioMedPartners AG
 BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Private Equity Investor | 2009-02-28 |
Novartis Venture Funds
 Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz. | Chief Investment Officer | 2006-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Novartis Venture Funds
Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz. | Finance |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Finance |
- Stock Market
- Insiders
- Frances Wildhaber
